1. Home
  2. MRNS vs SND Comparison

MRNS vs SND Comparison

Compare MRNS & SND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNS
  • SND
  • Stock Information
  • Founded
  • MRNS 2003
  • SND 2011
  • Country
  • MRNS United States
  • SND United States
  • Employees
  • MRNS N/A
  • SND N/A
  • Industry
  • MRNS Biotechnology: Pharmaceutical Preparations
  • SND Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • MRNS Health Care
  • SND Industrials
  • Exchange
  • MRNS Nasdaq
  • SND Nasdaq
  • Market Cap
  • MRNS 76.0M
  • SND 90.1M
  • IPO Year
  • MRNS 2014
  • SND 2016
  • Fundamental
  • Price
  • MRNS $1.55
  • SND $2.05
  • Analyst Decision
  • MRNS Buy
  • SND Hold
  • Analyst Count
  • MRNS 7
  • SND 2
  • Target Price
  • MRNS $8.00
  • SND $2.63
  • AVG Volume (30 Days)
  • MRNS 399.9K
  • SND 59.6K
  • Earning Date
  • MRNS 11-05-2024
  • SND 11-05-2024
  • Dividend Yield
  • MRNS N/A
  • SND N/A
  • EPS Growth
  • MRNS N/A
  • SND N/A
  • EPS
  • MRNS N/A
  • SND 0.03
  • Revenue
  • MRNS $30,263,000.00
  • SND $295,699,000.00
  • Revenue This Year
  • MRNS $20.42
  • SND N/A
  • Revenue Next Year
  • MRNS $57.03
  • SND N/A
  • P/E Ratio
  • MRNS N/A
  • SND $69.51
  • Revenue Growth
  • MRNS 16.56
  • SND N/A
  • 52 Week Low
  • MRNS $1.05
  • SND $1.65
  • 52 Week High
  • MRNS $11.26
  • SND $2.48
  • Technical
  • Relative Strength Index (RSI)
  • MRNS 66.10
  • SND 49.93
  • Support Level
  • MRNS $1.38
  • SND $1.96
  • Resistance Level
  • MRNS $1.43
  • SND $2.07
  • Average True Range (ATR)
  • MRNS 0.07
  • SND 0.07
  • MACD
  • MRNS 0.02
  • SND -0.01
  • Stochastic Oscillator
  • MRNS 79.25
  • SND 46.43

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

About SND Smart Sand Inc.

Smart Sand Inc is a fully integrated frac sand supply and services company that offers complete mine-to-well site proppant supply and logistics solutions. It produces Northern White frac sand, which is a premium proppant used to enhance hydrocarbon recovery rates in the hydraulic fracturing of oil and natural gas wells. Its product portfolio includes Smart System, which includes SmartBelt, SmartDepot Silo and SmartPath Loader. The company caters its products and services to oil and natural gas exploration and production companies and oilfield service companies. The majority of its revenue comes from Sand Sales, followed by logistics.

Share on Social Networks: